C M E

Pediatric Chronic Rhinosinusitis:
The Old, the New, and the Reasonable C hronic rhinosinusitis (CRS), has a significant effect on a child's quality of life. CRS may aggravate comorbid diseases and is often refractory to treatment. 1, 2 It is more frequently diagnosed in between the 4 and 7 years, whereas acute rhinosinusitis usually affects 1-to 5-year-old children.
The exact incidence of pediatric bacterial sinusitis is unknown. However, it may be inferred indirectly from the frequency of six to eight upper respiratory infections (URI) that children have every year, with 5% to 13% of these infections becoming acute bacterial rhinosinusitis. In adults, only 2% of viral URI become CRS. Similar information in children is not available.
A survey estimates the prevalence of CRS in the general adult population to 1 . Provide a working definition of pediatric chronic rhinosinusitis and differentiate this condition from that in adults.
2. Discuss the pathophysiology of chronic rhinosinusitis in children highlighting the role of infl ammation and biofi lms.
3. Determine the common comorbidities found with chronic rhinosinusitis in children and address treatment options for this condition.
Because children have frequent URIs and are prone to allergic rhinitis, both diseases with similar symptoms to CRS, it is hard to tell where one pathology ends and the other begins. 6 Suspicion of CRS in children may be decreased by the occasional belief that paranasal sinuses are not yet developed in the small child. 7 
ANATOMY AND PATHOPHYSIOLOGY
The paranasal sinuses are air-filled cavities in the bones of the head that communicate with the nasal passage through tubular openings (ostia). They are lined with a ciliated epithelium that sweeps mucus toward the ostia. The maxillary and ethmoid sinuses are the most commonly involved in young children's sinusitis and are present at birth. Their complete pneumatization is reached at about 12 years. Sphenoid sinuses begin to develop at 3 years, and frontal sinuses begin to appear at 7 years.
Pneumatization of these sinuses is completed in mid-to late adolescence. The frontal sinuses may remain underdeveloped in 15% of the population, while the sphenoid sinus is hypoplastic in 26% of the population. The prevalence of sinusitis increases after 6 to 8 years, marking the addition of the frontal sinuses as yet another site that can be affected by rhinosinusitis. 3, 5 
KEEPING SINUSES HEALTHY
Normal function of the sinuses requires that the ostia remain patent, the mucociliary function is normal, and the systemic and local immunity responses are appropriate. When all of these work well, sinuses generally remain sterile and transient, low-density bacterial contamination is dealt with effectively.
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THE ORIGINS OF DISEASE
Defective mucociliary clearance, obstructed sinus drainage, or a large microbial threat close to the sinuses may act individually or in combination to lead to the development of CRS.
Ostium patency is affected by mucosal infl ammation of any type or by mechanical obstruction. The mucosa in the nasopharynx and overlying adenoids and tonsils may harbor bacterial aggregates of more than 10 4 CFU/mL, constituting the source of infection for adjacent sinuses.
Blocked mucus drainage through the sinus ostia decreases oxygenation and lowers the pH inside the sinuses. These local conditions facilitate bacterial growth. Once purulent secretions form, they further contribute to the decrease of oxygenation in the sinuses. 5 CRS, however, does not result simply from obstruction to sinus drainage and exposure to microorganisms. The nasal epithelium mounts an inappropri- 
THE ROLE OF INFLAMMATION
Mucosal biopsy samples of CRS show intense infl ammation with eosinophils, neutrophils, and lymphocytes, as well as T-cell-produced cytokines and chemokines, in response to allergens, irritants, such as ozone or cigarette smoke, or exposure to bacterial superantigens.
Regardless of the inciting factor, the elevation in cellular constituents in CRS points to a vigorous immune response. 9 The effects of the released mediators are vasodilatation, increased mucus secretion, plasma extravasation, neurogenic infl ammation, and mast cell-nerve interactions. The resulting infl ammation leads to local changes that favor the development of infection, as previously described. Infl ammation and infection engage in a cycle that may explain in part the protracted nature of CRS.
Samples of sinus mucosa from young children (1 to 8 years) with CRS show a lymphocytic infi ltrate unlike in adults, in whom eosinophils and neutrophils prevail.
The eosinophilic remodeling with thickened basement membrane and submucosal gland hyperplasia seen in adults is not present in young children with CRS. These morphologic changes become apparent only in older children, suggesting that there may be a progression of sinus tissue damage from the very young to the adult type of CRS. Early diagnosis and treatment may prevent the long-lasting changes typical for CRS.
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ELEMENTS OF INFECTION
CRS used to be thought of essentially as an infection of the sinuses. Paralleling the recognition of its infl ammatory nature, there is increasing doubt about the role of infection in CRS. This may be partly caused by diffi culty identifying any pathogens on cultures of nasopharyngeal secretions, and the less-than-optimal effect of antibiotics that, in the absence of culture and sensitivity guidance, are used empirically. 6 Even when positive cultures are obtained, contamination with colonizing bacteria is often suspected.
From a more integrated perspective, numerous factors contribute to CRS, including infection, because it causes infl ammation. The lack of success in treating CRS with antimicrobials is explained by the fact that CRS is generally managed as a planktonic (free-fl oating) bacterial infection. However, ample evidence shows biofi lm to be present in surgically removed sinus mucosa from patients with CRS.
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BIOFILM IN INFECTION
A bacterial biofi lm consists of complex colonies of microbial cells that live within a self-produced polysaccharide matrix and are strongly adherent to surfaces, such as respiratory mucosa. Microorganisms cross-talk, a process called "quorum sensing." Within biofi lms, bacterial gene expression is different from in the planktonic state and metabolic requirements are reduced. 11 These adaptations render the biofi lm bacteria more resistant to antibiotics and to killing by immune factors. The reservoirs of biofi lm for sinuses are the adenoids, tonsils, and nasopharyngeal mucosa.
Biofi lm pathogen identifi cation requires research-based networks. Antibiotics best suited to treat biofi lms may need different characteristics than those effective against free-fl oating bacteria. Biofi lms associated with CRS are typically polymicrobial, commonly including Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus pneumoniae, coagulase-negative Staphylococci, Moraxella catarrhalis, Haemophilus infl uenzae, anaerobes, and even fungi.
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CLINICAL FEATURES
The usual symptoms of CRS in adult sand the most common presenting symptoms in children listed in Table   TABLE 2 .
Preparation and Use of an Isotonic Nasal Saline Solution
Percentage of NaCl Recipe
One-half tsp salt (about 3 g) with 250 mL boiled water
Optional: 1 tsp baking soda Preparation, use, and storage: measure salt and, if used, baking soda and mix in clean cup. Add previously boiled water while still warm. Cool to room temperature. Fill clean dispensing device (squeezing bottle, syringe, etc.) with solution. Rinse the nose two to four times a day. Do not put the used syringe, and do not plunge the used bottle tip, back into the solution while there is still, if any, solution in the cup as this will contaminate the remaining solution.
If a nasal steroid spray is also used, always use the salt and water mixture fi rst and never immediately after the steroid spray as you may wash out the medicated spray too fast.
The mixture may cause mild burning sensation the fi rst few times it is used; if this does not disappear in a few days, reduce the amount of salt.
Store any unused solution in a closed, clean container in the refrigerator for 2 to 3 days, then make a new solution. C M E 1 (see page 214) underscore the less specifi c symptomatology of CRS in children. Pediatric CRS may often masquerade as upper respiratory tract infections, otitis media, and slow growth. The symptoms are relatively age dependent. Very young children show irritability, easy fatigability, and poor eating. Young children may vomit from gagging on mucus or from coughing; they may snore, have restless sleep, sleep in abnormal positions, or have apnea.
The main complaints in older children may be general malaise, poor school performance, and decreased attention span, which are related to sleep deprivation. Fever and headaches are less common in pediatric CRS.
Findings on physical examination may be subtle and nonspecifi c, creating a challenge in diagnosis. On inspection, mouth breathing, coughing, abnormal voice, and halitosis may be noted. Percussion of the sinuses is rarely useful in children.
Examination of the nose with the otoscope is diffi cult in young children, but when it can be done it may reveal anatomical obstructions and masses, such as polyps or and foreign bodies. The turbinates may be swollen. Nasal mucosa does not have the normal pinkorange color with slight sheen that indicates good hydration. Mucopurulent to colorless secretions may be present in various amounts, or may be absent.
Foul-smelling mucus is often associated with a foreign body that has been placed into the nose. Concomitant erythema of the oral pharynx and signs of otitis media are common in CRS. Periorbital edema is more typically associated with ethmoid sinusitis. 3, 4, 5, 14 Complications occur rarely in CRS but include orbital infections or intracranial spread of the infection. Patients with these complications may experience severe consequences, including visual impairment, neurological deficit, or death. The diagnosis of these complications may be delayed because symptoms continue to resemble those of sinusitis. 14, 15 
PREDISPOSING FACTORS/ COMORBIDITIES
It is not clear whether host factors (systemic and local) and environmental conditions that affect CRS induce the disease or share a common pathway of pathogenesis with it. Following is a listing of these factors.
Environmental Factors
Viral URI is the most common predisposing factor for bacterial sinusitis. Attendance in day care facilities triples the incidence of URI. 5, 16 Viral rhinosinusitis causes nasal obstruction and abnormal mucociliary activity. 3 Symptoms that persist for weeks and months after a viral respiratory infection should raise consideration for an ongoing CRS. Increased exposure to bacteria or fungi heightens the risk of superimposed secondary infections.
Environmental exposure to tobacco smoke inhibits mucociliary clearance and epithelial regeneration. Noxious inhalants, such as ozone, chlorine, and or other pollutants, present as small particulate matter may irritate the nose and sinuses. 3, 17 Systemic host factors may cause or worsen CRS.
Allergic Rhinitis
Allergic infl ammation alters the sinonasal physiology with regards to mucociliary clearance and patency of the ostia. Late-phase allergic infl ammation may contribute to CRS development.
Immunotherapy for allergic rhinitis was shown to help in CRS. 4 However, it is still controversial whether allergy plays an important role. Overlapping symptoms make it diffi cult to differentiate between the two conditions.
In some studies, the prevalence of sensitization to aeroallergens in CRS patients is about the same as in the general pediatric population, whereas other studies show a higher prevalence of atopy in patients with CRS compared with the general population. Allergic-type infl ammation (elevated IgE, presence of IL-4) can be found even in the non-allergic CRS patients.
4,18
Local Allergic Rhinitis
Some
In some studies, nasal provocation tests to dust mite allergen were positive in 54% of patients thought to have idiopathic rhinitis. Nasal provocation tests were positive to seasonal allergens in 62.5% of patients with rhinitis and negative skin tests. It appears that local B cells in the nasal mucosa can become sensitized and produce specific IgE that binds to local mast cells.
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Nonallergic Rhinitis
From 17% to 52% of CRS is associated with nonallergic rhinitis, which has a 5% to 10% prevalence in the general population. Rhinitis triggered by allergic and non-allergic factors is considered mixed rhinitis.
5
Allergic Fungal Rhinitis
The role of fungi in the pathogenesis of CRS is unclear. Fungi are present in the air at all times and can be found in the normal nose. Allergic fungal rhinosinusitis (AFRS) is a noninvasive form of CRS, caused by a hypersensitive reaction to the inhaled fungi. This is the most common form of fungal CRS in children. 20 All children with AFRS are atopic, and almost all have nasal polyps. In children with unilateral asymmetrical nasal polyps, facial abnormalities, or proptosis, AFRS should be considered. Cough is often thought to be a symptom of asthma. However, in one-third of patients with a nocturnal cough, it is not asthma but CRS that causes the symptom. Chronic cough is a prominent symptom of CRS in children. The widely embraced concept of coughvariant asthma may decrease the likelihood that pediatricians will make the diagnosis of CRS.
4,21,22
Immunodefi ciency
Immunologic incompetence or immaturity may contribute to the pathophysiology of CRS in children. CRS, usually without polyps, is the most common complication of common variable immunodefi ciency (75%). 23, 24 Immunocompromise secondary to chemotherapy in children is associated with an increased incidence of CRS and invasive fungal sinusitis in these patients. 1 Immunodefi ciency is usually suspected when a patient has recurrent pulmonary infections and otitis media in addition to chronic rhinosinusitis, or when CRS is poorly responsive to usual therapy. 20 
Otitis Media with Effusion
Otitis media is often a presenting symptom of chronic rhinosinusitis. In one study, radiologic abnormalities in keeping with CRS were found in patients with otitis media refractory to treatment in half of the patients 10 to 20 years and in almost 80% of the 4-to 9-year-old children. 25 Because the middle ear has an anatomic and functional connection with the nasopharynx through the eustachian tube, the middle ear cavity is also a paranasal sinus. Nasal mucosal infl ammation may cause obstruction of this "sinus" ostia, (ie, the eustachian tube opening), leading to its dysfunction. Consequently, the middle ear pressure is impaired and fl uid accumulates. 21 
Gastrointestinal Issues
Gastroesophageal refl ux disease (GERD) is related to CRS in some pediatric patients, but its association with respiratory disease and remains in doubt. 1 Gastroesophageal refl ux is a physiological phenomenon at 3 to 4 months and naturally decreases thereafter, but it is still present in 20% of infants. Pharyngeal refl ux is documented in half of these children. 26 On the other hand, studies have shown that esophageal refl ux occurs in 63% of chronic rhinosinusitis patients and in only 5% of the general population. Nasopharyngeal refl ux was demonstrable in one-third of children in the CRS group. Treatment of GERD resulted in significantly improved sinus symptomatology for most patients, even when nasopharyngeal refl ux was not demonstrated. 27 In another study, therapy of coexisting GERD in children with refractory chronic rhinosinusitis often obviated the need for sinus surgery. 21, 28 The clinical diagnosis of GERD is diffi cult because children rarely complain of typical symptoms of heartburn, sour eructations, or regurgitation. They commonly have less specifi c manifestations, such as nausea and decreased appetite. 27 Refl ux of gastric acid into the pharynx and nasopharyx can cause sinus ostial infl ammation, impaired mucociliary clearance, and, consequently, sinusitis.
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Cystic Fibrosis
Cystic fi brosis (CF) is an autosomal recessive disease caused by a gene mutation that leads to formation of thick viscous secretions favoring infections in the respiratory tract. P. aeruginosa and S. aureus are the microorganisms most frequently cultured from the sinuses. 24 Nasal polyps are generally rare in children, but 5% to 86% of CF children have nasal polyps. Even in the absence of symptoms, most CF patients have chronic sinus infl ammation. The prevalence of CRS is increased even in heterozygotes when compared with normal populations. CF should be considered in children with nasal polyps or with CRS appearing at an early age.
5,24
LOCAL HOST-RELATED FACTORS
Primary ciliary dyskinesia is a rare genetic disease in which the sinonasal cilia are reduced in number and have abnormal morphology and function. All these predispose to infection. Biopsies to evaluate the morphology of cilia are diffi cult to interpret.
14 Interestingly, nasal polyps do not develop in primary ciliary dyskinesia, despite mucus stasis and infl ammation. 30 Mucocilliary dysfunction may also occur secondarily to infection. The morphology of cilia may become abnormal in the context of CRS itself, contributing to the self-perpetuating nature of the disease. Loss of ciliated epithelial cells occurs in rhinitis medicamentosa induced by topical decongestants, explaining the delay in a return to normalcy of the sinonasal mucosa even after discontinuation of the vasoconstrictor drugs. 31 Anatomic abnormalities that cause nasal obstruction may be conducive to unilateral or bilateral sinusitis. Septal dislocation caused by birth trauma, unilateral choanal atresia, nasal fractures, foreign body in the nose, septal deviation, or concha bullosae (middle turbinates aerated from the ethmoids) can cause blockage. Dental infections may spread into the sinuses, causing odontogenic sinusitis. 8 A family history of asthma or inhalant allergies appears to be a risk factor for the development of pediatric CRS. C M E
CHALLENGES IN DIAGNOSIS
The history should elicit information regarding specifi c symptoms and pattern of symptoms to assess exacerbations and complications, precipitating factors, existing comorbid conditions, environmental exposure, personal and family medical history of atopy, and response to therapy. A particular challenge for the pediatrician is to differentiate true CRS from frequent URI, or perennial allergic rhinitis with overlapping manifestations.
A handheld otoscope or a head lamp with nasal speculum are usually appropriate for a nasal examination to look for purulent discharge, swelling, and other mucosal changes. Nasal endoscopy may be diffi cult in young children because it requires cooperation. In older children, it may be satisfactorily carried out after a topical decongestant and a local anesthetic spray. 5 Transillumination of sinuses is not reliable in children. It may be useful only if complete opacifi cation is present.
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IMAGING
Sinus X-rays are discouraged, except for exceptional circumstances. Sinus X-rays are non-specifi c and insensitive, with many false positive and false negative results. Only the Caldwell and Waters views are helpful in children younger than 4 years; lateral views may be added for older than 4 years. Sinus X-rays are technically diffi cult if the child is uncooperative and or if positioning is incorrect. 5, 14, 15 A computerized tomography (CT) scan is not necessary for the diagnosis. It is the imaging modality of choice only in presurgical cases. The radiation doses delivered are higher than plain X-ray, and thus are a concern for children. 5, 15 The American Academy of Pediatric Section on Radiology states that "pediatric health care professionals' role is to decide when CT is necessary and to discuss the risk with the patient and family." Some specialists believe that sinus CT scan is reasonable if a child has failed to respond to 3 weeks of antibiotic therapy and CRS is suspected.
Contrast media is not generally needed, unless complications are suspected. CT scan should be done urgently in proptosis, impaired eye movement, or vision because of orbital complications; CT scan should be done emergently if an intracranial spread of sinusitis is suspected (severe headache, vomiting, altered sensorium). 5 Magnetic resonance imaging (MRI) is generally not practical because of its high cost and sedation requirements. It can differentiate between sinus secretions and mucosal thickening, between infl ammation and malignancy, and is very useful in chronic fungal sinusitis.
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PATHOGEN IDENTIFICATION
Bacterial recovery is not recommended when deciding on management. Empiric treatment may be started once the clinical diagnosis of CRS is made. Nasal and postnasal discharge cultures are not reliable. Maxillary sinus puncture is the gold standard to retrieve relevant microorganisms; a drawback is that it refl ects only the pathology in the maxillary sinus.
It is an invasive and uncomfortable procedure, performed only by otolaryngologists. To correctly identify pathogens in biofi lm tissue, the sample requires tests used only in research. Fungal cultures are never required in children, because their form of fungal CRS is not invasive. 4 
COMORBID CONDITIONS
When allergies or asthma are suspected, a full work-up by an allergist is indicated, which may include an environmental assessment, skin tests, nasal provocation tests, and pulmonary function tests as deemed necessary. When immunodefi ciency is suspected, immunoglobulins and lymphocytes should be assessed.
Investigations for GERD involve pH esophageal monitoring, if symptoms suggest this condition. For CF, a sweat chloride test should be done.
To diagnose mucociliary dyskinesia, a mucosal biopsy may be done. 14, 19, 21, 27 MEDICAL OR SURGICAL TREATMENT Treatment of CRS in children has medical and surgical components. Initial therapy should be medical, except where obvious anatomic obstruction requires surgical relief.
Medical treatment should address both the infl ammatory and infectious components. CRS is now recognized as a multifactorial infl ammatory disorder rather than a mere persistent bacterial infection. Nonetheless, sinus drainage is impaired in all forms of CRS, leading to secondary bacterial infections. Typically, relatively long-term courses of antibiotics are needed to treat acute relapses of CRS, based on experience in adults. 5, 6 Antibiotics are given over 3 to 4 weeks, rarely longer, until the patient is symptom-free for 7 to 14 days. Short-term courses are inadequate. 32 The antimicrobial agent covers a polymicrobial infection with aerobic and anaerobic bacteria.
These are shielded by the biofi lm structure, exhibit certain resistance patterns, and produce beta-lactamase. Taking these issues into consideration allows effective empiric use of antimicrobials, despite the lack of reliable culture/susceptibility results in most cases. In the future, polymerase chain reaction testing on biofi lm tissue may lead to more accurate identifi cation of pathogens to guide therapy.
Studies have showed amoxicillinclavulanic acid or cefuroxime axetil provide good fi rst-line treatment. 4 Macrolides, with anti-infl ammatory effects in addition to their antibacterial activity, may be better than other classes of antibiotics in treating biofi lm infection.
C M E
Treatment data are mostly derived from adult studies and can only be extrapolated to pediatric CRS. 11 Clindamycin, the "newer" quinolones (levofl oxacin, moxifl oxacin), and cephalosporins other than fi rst generation have all been used successfully.
For methicillin-resistant S. aureus, a clindamycin and sulfamethoxazoletrimethoprim combination was reported to be effective. 6 The effectiveness of topical antibiotics and antifungals has not been proven. 4 Antifungals are not recommended because there is no evidence of effectiveness. 21 Nasal steroid sprays are being widely used to decrease infl ammation from CRS, based mostly on anecdotal evidence. However, a recent literature review has confi rmed that they provide a modest benefi t. Some preparations have been reported to reduce linear growth, at least temporarily.
Mometasone furoate is the only intranasal corticosteroid approved for patients older than 2 years. This drug has no long-term effect on growth or the pituitary axis. Fluticasone propionate is approved for those older than 4 years. 6 Oral corticosteroids are probably safe and effective when given in short bursts for severe symptoms of CRS; repeated or prolonged use signifi cantly enhances the risk of side effects. 33 Adjunctive therapies in children include oral antihistamine if allergy is present. In the absence of allergies, antihistamines are not used to treat bacterial sinusitis because they can thicken and dry secretions.
Saline nasal washes help remove crusts, infective agents, and infl ammatory mediators, liquefy secretions, act as a mild vasoconstrictor on nasal blood fl ow, and provide symptom relief. They show consistent evidence of benefi t and are recommended as adjunct in the therapy of CRS. 4, 32 Nasal saline washes at concentration of isotonic saline (0.9%) or hypertonic saline are commercially available or can be home-made. Instructions for preparation and use of a common regimen of an isotonic nasal saline solutions are presented in Table 2 (see page 215) .
Oral mucolytics, such as guaifenisin, may benefi t symptoms of CRS. Proven to be an effective expectorant, its use remains empiric in CRS. It has no side effects, and it is recommended for symptomatic relief. 4 Antileukotrienes have no proven effi cacy in CRS. 21 Preventing and treating comorbid conditions include antirefl ux therapy in GERD, 12, 24 environmental control for allergen, smoke, and pollutants exposure. 21 Antibiotic-associated diarrhea occurs in 11% to 31% of children treated with antibiotics.
The potential role of probiotics in reducing the risk of this complication has been studied with increasing interest. While inconclusive results exist, some studies and meta-analyses of trials found evidence that probiotics given during antibiotherapy, either as single agents (ie, Lactobacilus) or as yogurt containing active bacterial culture, decreased signifi cantly the incidence of diarrhea in these children. They are safe to be used except in patients with a compromised integrity of the barrier of the intestine, those with short gut syndrome, the immunocompromised, and patients with central venous catheter. A large proportion of recently surveyed gastroenterologists confi rmed they recommend probiotics in selected patients taking antibiotics.
34-37
SURGICAL TREATMENT
Surgery is rarely indicated and should be considered as a last resort in the pediatric population. 5 Adenoidectomy is the fi rst-line surgical step to remove the reservoir of biofi lm for chronic sinus infection. Functional endoscopic sinus surgery (FESS) can be done to enlarge natural ostia and to correct anatomic deformities bearing an effect on CRS. It may be considered when there is no improvement with maximal medical therapy, in failed adenoidectomy, in CF, ciliary dyskinesia, patients with immunodefi ciency and allergic fungal sinusitis. There are concerns of hindering midface growth in children undergoing this procedure, with confl icting data.
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WHEN TO REFER A PATIENT WITH CRS
Specialist consultation should be sought when:
The allergic or immunologic basis of a case of CRS needs to be clarifi ed; There is refractoriness to appropriate treatment; There are frequent exacerbations that will severely affect the child's quality of life and performance; There are opportunistic infections, symptoms and signs suggestive of CRS complications; or Comorbid factors need further assessment (ie, GERD).
SUMMARY
Pediatric CRS may present with subtle, nonspecifi c symptoms, not always matching the criteria of diagnosis established for adults. It is a multifactorial disease and it requires a comprehensive and sometimes a multidisciplinary approach. As a biofi lm infection, CRS needs therapy that takes this fact into consideration. Use of probiotics in conjunction with antibiotics in selected patients may reduce the risk of antibiotic-associated diarrhea.
Our understanding of the role of predisposing/comorbid factors is evolving. The concept of local rhinitis may change the thinking about the involvement of allergy in CRS. Appropriate work-up should take into consideration these factors as clinically indicated.
Histopathologic data may indicate that there is progression in the severity of tissue damage over time and that early diagnosis and treatment may prevent this progression. 
